Experiments using transgenic murine models have provided evidence that PI3K/Akt signaling is a critical determinant of β-cell mass and function whose impairment is supposed to be an early feature of pathogenesis in type 1 and type 2 diabetes (Chen et al., 2017). Here, AKT1 is linked to type 2 diabetes mellitus.